title: Re: Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the reduction by dutasteride of prostate cancer events trial.
authors.affiliation: Department of Urology, Hannover Medical School, Hannover, Germany. oelke.matthias@mh-hannover.de
authors.forename: Matthias
authors.initials: M
authors.lastname: Oelke